HEPATIC ENCEPHALOPATHY MARKET ANALYSIS

Hepatic Encephalopathy Market, by Drug Class (Antibiotics, Laxatives, L-ornithine L-aspartate, and others), by Route of administration (Oral, Intravenous, Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI2596
Pages :210
Formats :
Excel and PDF
Industry : Pharmaceutical

Hepatic Encephalopathy MarketSize and Trends

Global Hepatic Encephalopathy Market is estimated to be valued at US$ 403.3 million in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030). Increase in product launches by key market players is expected to drive the market growth during the forecast period. Moreover, an increase in prevalence of disease such as jaundice and others is also expected to drive the market growth.

Figure 1. Global Hepatic Encephalopathy Market Share (%), By Drug Class, 2023

Based on Drug Class, the market is segmented into hepatic encephalopathy, antibiotics, laxatives, l-ornithine l-aspartate and others. Out of which, the antibiotics is segment is expected to dominate the global hepatic encephalopathy market during the forecast period owing to the increasing product launches and approvals by the major market players.